×
For best experience we recommend to activate Javascript in your browser.
ACADS antibody (AA 25-412)
Acads
Reactivity: Human
WB, ELISA, IF, ICC
Host: Mouse
Monoclonal
AT8B10
unconjugated
Product Details anti-ACADS Antibody
(hide)
Target
See all ACADS (Acads) Antibodies
ACADS (Acads)
(Acyl-CoA Dehydrogenase, C-2 To C-3 Short Chain (Acads))
Binding Specificity
All epitopes for ACADS antibodies
AA 25-412
Reactivity
All reactivities for ACADS antibodies
Human
Host
All hosts for ACADS antibodies
Mouse
Clonality
All clonalities for ACADS antibodies
Monoclonal
Conjugate
All conjugates for ACADS antibodies
This ACADS antibody is un-conjugated
Application
All applications for ACADS antibodies
Western Blotting (WB), ELISA, Immunofluorescence (IF), Immunocytochemistry (ICC)
Immunogen
Recombinant human ACADS (25-412aa) purified from E. coli
Clone
AT8B10
Isotype
IgG2a kappa
Top Product
Discover our top product Acads Primary Antibody
Alternatives
(show)
Application Details
(hide)
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Concentration
1 mg/mL
Storage
4 °C,-20 °C,-80 °C
Storage Comment
Can be stored at +2°C to +8°C for 1 week. For long term storage, aliquot and store at -20°C to -80°C. Avoid repeated freezing and thawing cycles.
Target Details for ACADS
(hide)
Target
ACADS (Acads)
(Acyl-CoA Dehydrogenase, C-2 To C-3 Short Chain (Acads))
Alternative Name
ACADS (Acads Products )
Background
ACADS (Acyl-Coenzyme A dehydrogenase), also known as SCAD or ACAD3, is a tetrameric mitochondrial flavoprotein, which is a member of the acyl-CoA dehydrogenase family. This enzyme catalyzes the initial step of the mitochondrial fatty acid beta-oxidation pathway. Mutations of ACADS have been associated with fatty acid oxidation defects and metabolic diseases such as short-chain acyl-CoA dehydrogenase deficiency (SCAD deficiency).
Pathways
Monocarboxylic Acid Catabolic Process
Recently viewed
(hide)